84a16c87 6397 1d47 E053 2a91aa0a30e8
Tamsulosin Hydrochloride Capsule
Product Images NDC 68084-299
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 68084-299). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Blister
Tamsulosin Hydrochloride is a medication used in the treatment of symptoms associated with an enlarged prostate gland. The medication's strength ranges from 0.4 mg to 4 mg.*
Carton
This is a medication called Tamsulosin Hydrochloride. It comes in the form of capsules and is available in a bottle containing 100 capsules. The usual dosage instructions are included in a package insert. Store this medication at 20° to 25°C (68" to 77°F), with permitted excursions between 15° to 30°C (59" to 86°F) [see USP Controlled Room Temperature]. The medication should be kept out of reach of children. The drug product is from NDC # 68382-132, Zydus Pharmaceuticals USA Inc. It is distributed by American Health Packaging in Columbus, Ohio.*
Figure 1
Figure 2a
This is a table showing the mean change in treatment over different weeks for a group of patients. The treatment involved a combination of different doses of medication and a placebo group. The number of patients in each group also varies across different weeks. There is no available information regarding the actual medication or medical condition being treated.*
Figure 2b
This appears to be a table with headings "Mean Change" and "Treatment". The treatment column has three values: "-0-0-0-08mg", "A A-A-0.4 mg", and "Placebo". The table also has several rows with dashes and "T" characters, and numbers from 1 to 13 and "LOCF". It is not clear what these rows represent. The last row shows the duration of treatment in weeks. It is not possible to determine the context or purpose of this table from this text alone.*
Figure 3a
This appears to be a table showing the mean change in treatment for a particular duration of treatment (in weeks), with three different treatment types (0.08mg, 0.4mg, and placebo). The table also includes LOCF (last observation carried forward) data for weeks 4, 7, 10, and 13. However, some characters are unreadable and cannot be interpreted.*
Figure 3b
Structure
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
